Shogo Misumi

10PUBLICATIONS
65CO-AUTHORS
Molecular targetsGlycoconjugatesCardiology (incl. cardiovascular diseases)Biologically active moleculesGenetic immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 28, 2026
Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity.

Belgin Sever, Cüneyt Türkeş, Yeliz Demir

|Dec 04, 2025
Targeting envelope lipids with 2,6‑di‑O‑methyl‑3‑acetyl‑β‑cyclodextrin impairs infectivity of SARS‑CoV‑2 and Japanese encephalitis virus.

Daichi Kusakari, Naoki Kishimoto, Kazuyuki Oshiro

|Jun 13, 2025
Structural basis of the hepatitis B virus X protein in complex with DDB1.

Hiroki Tanaka, Joao Diogo Dias, Basile Jay

|Jan 20, 2025
An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.

Nobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi

|Jul 12, 2023
GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants.

Manabu Aoki, Hiromi Aoki-Ogata, Haydar Bulut

|May 05, 2023
CyclosporinA Derivative as Therapeutic Candidate for Alport Syndrome by Inducing Mutant Type IV Collagen Secretion.

Jun Kuwazuru, Mary Ann Suico, Kohei Omachi

Pageof 2

Frequent Collaborators

5 joint publications

Naoki Kishimoto

4 joint publications

Shin-Ichiro Hattori

4 joint publications

Nobuyo Higashi-Kuwata

4 joint publications

Haydar Bulut